• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度认知障碍和阿尔茨海默病的区域代谢模式:一项氢质子磁共振波谱研究

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.

作者信息

Kantarci K, Jack C R, Xu Y C, Campeau N G, O'Brien P C, Smith G E, Ivnik R J, Boeve B F, Kokmen E, Tangalos E G, Petersen R C

机构信息

Departments of Diagnostic Radiology, Mayo Clinic, Rochester, MN, USA.

出版信息

Neurology. 2000 Jul 25;55(2):210-7. doi: 10.1212/wnl.55.2.210.

DOI:10.1212/wnl.55.2.210
PMID:10908893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2771162/
Abstract

BACKGROUND

Mild cognitive impairment (MCI) is a recently described transitional clinical state between normal aging and AD. Assuming that amnestic MCI patients had pathologic changes corresponding to an early phase and probable AD patients to a later phase of the disease progression, the authors could approximate the temporal course of proton MR spectroscopic (1H MRS) alterations in AD with a cross-sectional sampling scheme.

METHODS

The authors compared 1H MRS findings in the superior temporal lobe, posterior cingulate gyri, and medial occipital lobe in 21 patients with MCI, 21 patients with probable AD, and 63 elderly controls. These areas are known to be involved at different neurofibrillary pathologic stages of AD.

RESULTS

The N-acetylaspartate (NAA)/creatine (Cr) ratios were significantly lower in AD patients compared to both MCI and normal control subjects in the left superior temporal and the posterior cingulate volumes of interest (VOI) and there were no between-group differences in the medial occipital VOI. Myoinositol (MI)/Cr ratios measured from the posterior cingulate VOI were significantly higher in both MCI and AD patients than controls. The choline (Cho)/Cr ratios measured from the posterior cingulate VOI were higher in AD patients compared to both MCI and control subjects.

CONCLUSION

These findings suggest that the initial 1H MRS change in the pathologic progression of AD is an increase in MI/Cr. A decrease in NAA/Cr and an increase in Cho/Cr develop later in the disease course.

摘要

背景

轻度认知障碍(MCI)是最近描述的一种介于正常衰老和阿尔茨海默病(AD)之间的过渡性临床状态。假设遗忘型MCI患者具有与疾病进展早期相对应的病理变化,而可能的AD患者具有与疾病进展后期相对应的病理变化,作者可以通过横断面抽样方案来大致了解AD中质子磁共振波谱(1H MRS)改变的时间进程。

方法

作者比较了21例MCI患者、21例可能的AD患者和63例老年对照者颞上叶、扣带回后部和枕叶内侧的1H MRS结果。已知这些区域在AD的不同神经纤维病理阶段会受累。

结果

在左侧颞上叶和扣带回后部感兴趣区(VOI),AD患者的N-乙酰天门冬氨酸(NAA)/肌酸(Cr)比值显著低于MCI患者和正常对照者,而枕叶内侧VOI在组间无差异。在扣带回后部VOI测量的肌醇(MI)/Cr比值在MCI患者和AD患者中均显著高于对照者。在扣带回后部VOI测量的胆碱(Cho)/Cr比值在AD患者中高于MCI患者和对照者。

结论

这些发现表明,AD病理进展中最初的1H MRS变化是MI/Cr升高。NAA/Cr降低和Cho/Cr升高在疾病进程后期出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/f1c7e2049881/nihms-150996-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/7494d1396150/nihms-150996-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/ddb02c2e6b7b/nihms-150996-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/f3f10df5d711/nihms-150996-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/448f8fbec2d3/nihms-150996-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/f1c7e2049881/nihms-150996-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/7494d1396150/nihms-150996-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/ddb02c2e6b7b/nihms-150996-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/f3f10df5d711/nihms-150996-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/448f8fbec2d3/nihms-150996-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ea/2771162/f1c7e2049881/nihms-150996-f0005.jpg

相似文献

1
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.轻度认知障碍和阿尔茨海默病的区域代谢模式:一项氢质子磁共振波谱研究
Neurology. 2000 Jul 25;55(2):210-7. doi: 10.1212/wnl.55.2.210.
2
Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.采用3特斯拉磁共振波谱检测轻度认知障碍和阿尔茨海默病患者海马体和后扣带回区域的代谢变化。
Acta Radiol. 2009 Apr;50(3):312-9. doi: 10.1080/02841850802709219.
3
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).患者轻度认知障碍(MCI)质子磁共振波谱(1H MRS)中 N-乙酰天门冬氨酸、胆碱、肌醇、谷氨酰胺和谷氨酸(glx)浓度的变化。
Med Sci Monit. 2011 Dec;17(12):MT105-11. doi: 10.12659/msm.882112.
4
Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.利用质子磁共振波谱分析来识别轻度认知障碍。
Int Psychogeriatr. 2012 Jan;24(1):19-27. doi: 10.1017/S1041610211000962. Epub 2011 Jun 16.
5
A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.前扣带回中N-乙酰天门冬氨酸减少和肌醇增加与阿尔茨海默病的行为和心理症状相关。
J Neurol Sci. 2007 Sep 15;260(1-2):132-8. doi: 10.1016/j.jns.2007.04.017. Epub 2007 May 30.
6
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病中的海马体代谢异常。
Neurosci Lett. 2005;384(1-2):23-8. doi: 10.1016/j.neulet.2005.04.035.
7
(1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.(1)轻度认知障碍和轻度阿尔茨海默病患者前扣带回和后扣带回的氢质子磁共振波谱不对称性变化。
Compr Psychiatry. 2016 Aug;69:179-85. doi: 10.1016/j.comppsych.2016.06.001. Epub 2016 Jun 9.
8
Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.采用 3 特斯拉磁共振波谱技术对阿尔茨海默病谱系中扣带回前回和后回的代谢产物进行研究。
Dement Geriatr Cogn Disord. 2012;33(2-3):149-55. doi: 10.1159/000338177. Epub 2012 May 7.
9
Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.阿尔茨海默病的 1H-MR 光谱和脑脊液生物标志物的相关性:三个不同脑区的不同行为。
J Alzheimers Dis. 2013;36(1):155-63. doi: 10.3233/JAD-120778.
10
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.阿尔茨海默病颞叶的体内质子磁共振波谱分析
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22. doi: 10.1016/j.pnpbp.2004.08.013.

引用本文的文献

1
Ultrafast J-resolved magnetic resonance spectroscopic imaging for high-resolution metabolic brain imaging.用于高分辨率代谢脑成像的超快J分辨磁共振波谱成像
Nat Biomed Eng. 2025 Jun 20. doi: 10.1038/s41551-025-01418-4.
2
Associations between Aβ deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI-PET imaging.阿尔茨海默病中β淀粉样蛋白沉积与神经代谢改变之间的关联:来自混合3D磁共振波谱成像-正电子发射断层显像的见解
Alzheimers Dement. 2025 Jun;21(6):e70332. doi: 10.1002/alz.70332.
3
Biomarkers in Alzheimer's disease: new frontiers with olfactory models.

本文引用的文献

1
Memory and mental status correlates of modified Braak staging.改良Braak分期的记忆与精神状态相关性
Neurobiol Aging. 1999 Nov-Dec;20(6):573-9. doi: 10.1016/s0197-4580(99)00063-9.
2
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.基于磁共振成像的海马体积预测轻度认知障碍中的阿尔茨海默病
Neurology. 1999 Apr 22;52(7):1397-403. doi: 10.1212/wnl.52.7.1397.
3
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.衰老及阿尔茨海默病中神经原纤维变性的生化途径。
阿尔茨海默病中的生物标志物:嗅觉模型的新前沿
Inflammopharmacology. 2025 May 1. doi: 10.1007/s10787-025-01705-1.
4
A fusion analytic framework for investigating functional brain connectivity differences using resting-state fMRI.一种用于使用静息态功能磁共振成像研究大脑功能连接差异的融合分析框架。
Front Neurosci. 2024 Dec 11;18:1402657. doi: 10.3389/fnins.2024.1402657. eCollection 2024.
5
Cerebellar Structural and N-Acetylaspartate, Choline, and Creatine Metabolic Profiles in Parkinson's Disease and Essential Tremor.帕金森病和特发性震颤的小脑结构以及N-乙酰天门冬氨酸、胆碱和肌酸代谢特征
Diagnostics (Basel). 2024 Oct 30;14(21):2430. doi: 10.3390/diagnostics14212430.
6
Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer's Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE Genotype.使用阿尔茨海默病生物体液、PET、尸检病理学生物标志物和 APOE 基因型了解质子磁共振波谱神经化学变化。
Int J Mol Sci. 2024 Sep 19;25(18):10064. doi: 10.3390/ijms251810064.
7
Neurometabolic topography and associations with cognition in Alzheimer's disease: A whole-brain high-resolution 3D MRSI study.阿尔茨海默病的神经代谢拓扑结构及其与认知的关联:全脑高分辨率 3D MRSI 研究。
Alzheimers Dement. 2024 Sep;20(9):6407-6422. doi: 10.1002/alz.14137. Epub 2024 Jul 29.
8
Neuroimaging modalities in the detection of Alzheimer's disease-associated biomarkers.用于检测阿尔茨海默病相关生物标志物的神经成像模态
Psychoradiology. 2023 Jun 22;3:kkad009. doi: 10.1093/psyrad/kkad009. eCollection 2023.
9
Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.磁共振波谱分析(MRS)在阿尔茨海默病中的应用。
Methods Mol Biol. 2024;2785:115-142. doi: 10.1007/978-1-0716-3774-6_9.
10
Meta-analysis and open-source database for in vivo brain Magnetic Resonance spectroscopy in health and disease.用于健康和疾病中体内脑磁共振波谱的荟萃分析和开源数据库。
Anal Biochem. 2023 Sep 1;676:115227. doi: 10.1016/j.ab.2023.115227. Epub 2023 Jul 7.
Neurology. 1999 Apr 12;52(6):1158-65. doi: 10.1212/wnl.52.6.1158.
4
Brain proton spectroscopy in dementia: an aid to clinical diagnosis.痴呆症中的脑质子磁共振波谱分析:对临床诊断的辅助作用
Lancet. 1999 Mar 27;353(9158):1063-4. doi: 10.1016/s0140-6736(98)03759-3.
5
Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.载脂蛋白E4会加剧阿尔茨海默病死后大脑中的代谢改变。
Neurobiol Aging. 1998 Nov-Dec;19(6):511-5. doi: 10.1016/s0197-4580(98)00105-5.
6
Mild cognitive impairment: clinical characterization and outcome.轻度认知障碍:临床特征与转归
Arch Neurol. 1999 Mar;56(3):303-8. doi: 10.1001/archneur.56.3.303.
7
In vivo MR spectroscopy of human dementia.人类痴呆症的活体磁共振波谱分析
Neuroimaging Clin N Am. 1998 Nov;8(4):809-22.
8
Proton MR spectroscopy of common brain tumors.常见脑肿瘤的质子磁共振波谱分析
Neuroimaging Clin N Am. 1998 Nov;8(4):733-52.
9
Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities.阿尔茨海默病:病因、病理生理学、认知储备及治疗机遇。
Neurology. 1998 Jul;51(1 Suppl 1):S2-17; discussion S65-7. doi: 10.1212/wnl.51.1_suppl_1.s2.
10
Preclinical prediction of Alzheimer's disease using SPECT.使用单光子发射计算机断层扫描(SPECT)对阿尔茨海默病进行临床前预测。
Neurology. 1998 Jun;50(6):1563-71. doi: 10.1212/wnl.50.6.1563.